Atomistry » Chlorine » PDB 6zpd-6zyu » 6zux
Atomistry »
  Chlorine »
    PDB 6zpd-6zyu »
      6zux »

Chlorine in PDB 6zux: Crystal Structure of Thrombin in Complex with COMPOUND42A

Enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND42A

All present enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND42A:
3.4.21.5;

Protein crystallography data

The structure of Crystal Structure of Thrombin in Complex with COMPOUND42A, PDB code: 6zux was solved by M.Schafer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 71.25 / 1.94
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 70.260, 71.300, 72.450, 90.00, 100.43, 90.00
R / Rfree (%) 16.2 / 20.6

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Thrombin in Complex with COMPOUND42A (pdb code 6zux). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Thrombin in Complex with COMPOUND42A, PDB code: 6zux:

Chlorine binding site 1 out of 1 in 6zux

Go back to Chlorine Binding Sites List in 6zux
Chlorine binding site 1 out of 1 in the Crystal Structure of Thrombin in Complex with COMPOUND42A


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Thrombin in Complex with COMPOUND42A within 5.0Å range:
probe atom residue distance (Å) B Occ
H:Cl1001

b:20.1
occ:1.00
CL1 H:QQE1001 0.0 20.1 1.0
C15 H:QQE1001 1.7 19.7 1.0
C14 H:QQE1001 2.7 20.7 1.0
C16 H:QQE1001 2.7 19.2 1.0
O H:PHE227 3.2 18.4 1.0
O H:TRP215 3.4 19.3 1.0
N H:PHE227 3.5 17.8 1.0
CA H:GLY226 3.6 19.4 1.0
CG1 H:VAL213 3.6 18.1 1.0
N H:TRP215 3.6 18.2 1.0
N H:SER214 3.7 17.8 1.0
C H:TRP215 3.8 19.6 1.0
C H:GLY226 3.8 18.9 1.0
CZ H:TYR228 3.9 17.9 1.0
C H:PHE227 4.0 18.5 1.0
C13 H:QQE1001 4.0 20.6 1.0
C11 H:QQE1001 4.0 19.1 1.0
CE1 H:TYR228 4.1 18.5 1.0
OH H:TYR228 4.1 17.9 1.0
CE2 H:TYR228 4.1 17.1 1.0
CA H:TRP215 4.1 18.8 1.0
C H:SER214 4.2 18.9 1.0
CA H:PHE227 4.4 18.1 1.0
CA H:VAL213 4.4 17.3 1.0
CB H:ALA190 4.4 20.6 1.0
C H:VAL213 4.4 17.8 1.0
C12 H:QQE1001 4.5 19.7 1.0
N H:GLY216 4.5 20.1 1.0
CD1 H:TYR228 4.5 18.6 1.0
CA H:SER214 4.6 18.6 1.0
CD2 H:TYR228 4.6 17.6 1.0
CB H:VAL213 4.6 18.0 1.0
CG H:TYR228 4.7 18.4 1.0
O H:GLY226 4.8 19.9 1.0
OD1 H:ASP189 4.8 20.5 1.0
O H:SER214 4.9 20.4 1.0
O H:HOH1162 4.9 18.8 1.0
N H:TYR228 5.0 17.5 1.0
N H:GLY226 5.0 19.8 1.0

Reference:

A.Hillisch, K.M.Gericke, S.Allerheiligen, S.Roehrig, M.Schaefer, A.Tersteegen, S.Schulz, P.Lienau, M.Gnoth, V.Puetter, R.C.Hillig, S.Heitmeier. Design, Synthesis, and Pharmacological Characterization of A Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics. J.Med.Chem. V. 63 12574 2020.
ISSN: ISSN 0022-2623
PubMed: 33108181
DOI: 10.1021/ACS.JMEDCHEM.0C01035
Page generated: Mon Jul 29 18:13:01 2024

Last articles

Cl in 3LY2
Cl in 3LZ0
Cl in 3LUB
Cl in 3LXT
Cl in 3LXV
Cl in 3LWF
Cl in 3LXQ
Cl in 3LX4
Cl in 3LVP
Cl in 3LW1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy